Jubilant HollisterStier has entered into a multi-year contract with a major U.S. pharma company to manufacture an OTC women’s health product. The contract has a total value of more than $70 million for a four-year period, with a possibility of a two-year extension. Production of the product began earlier this month at the company’s manufacturing facility in Montreal, Canada. Shyam S. Bhartia, chairman and managing director, and Hari S Bhartia, co-chairman and managing director, Jubilant Life Sc...